CVE:ACST - Acasti Pharma Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started C$1.45 -0.08 (-5.23 %) (As of 01/16/2019 08:05 AM ET)Previous CloseC$1.53Today's RangeC$1.42 - C$1.5452-Week RangeC$0.57 - C$2.29Volume139,100 shsAverage Volume126,199 shsMarket CapitalizationN/AP/E Ratio-0.89Dividend YieldN/ABetaN/A ProfileDiscussionChartInsider TradesHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of cardiovascular diseases. Its lead product candidate is CaPre, an omega-3 phospholipid therapeutic that is in Phase III clinical trial to treat patients with hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada. Receive ACST News and Ratings via Email Sign-up to receive the latest news and ratings for ACST and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange CVE Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolCVE:ACST Previous SymbolCVE:APO CUSIPN/A Webwww.acastipharma.com Phone+1-450-6864555Debt Debt-to-Equity Ratio22.06 Current Ratio0.56 Quick Ratio0.54Price-To-Earnings Trailing P/E Ratio-0.89 Forward P/E Ratio-6.90 P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowC$0.07 per share Price / Cash Flow19.47 Book ValueC($0.40) per share Price / Book-3.59Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares78,102,000Market CapC$0.00 OptionableNot Optionable Acasti Pharma (CVE:ACST) Frequently Asked Questions What is Acasti Pharma's stock symbol? Acasti Pharma trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ACST." Has Acasti Pharma been receiving favorable news coverage? Media coverage about ACST stock has trended positive this week, according to InfoTrie Sentiment. The research firm identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Acasti Pharma earned a coverage optimism score of 2.8 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 7.0 out of 10, indicating that recent press coverage is likely to have an impact on the stock's share price in the next few days. Who are some of Acasti Pharma's key competitors? Some companies that are related to Acasti Pharma include 22nd Century Group (XXII), 4d Pharma (DDDD), Abattis Bioceuticals (ATTBF), Abcam (ABC), ABcann Global (ABCN), ABLYNX NV/ADR (ABLX), ABZENA/PAR VTG FPD 0.002 (ABZA), Acrux (ACR), Actinium Pharmaceuticals (ATNM), Actinogen Medical (ACW), Almirall (LBTSF), Altimmune (ALT), Ampio Pharmaceuticals (AMPE), Ampliphi Biosciences (APHB) and Antibe Therapeutics (ATE). Who are Acasti Pharma's key executives? Acasti Pharma's management team includes the folowing people: Ms. Janelle D' Alvise, Pres, CEO & DirectorMs. Linda P. O'Keefe, CFO & Sec.Dr. Pierre Lemieux, Chief Operating OfficerMr. Brian James Groch, Chief Commercial Officer (Age 51) How do I buy shares of Acasti Pharma? Shares of ACST and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab. What is Acasti Pharma's stock price today? One share of ACST stock can currently be purchased for approximately C$1.45. What is Acasti Pharma's official website? The official website for Acasti Pharma is http://www.acastipharma.com/. How can I contact Acasti Pharma? Acasti Pharma's mailing address is 545 Prom du Centropolis Suite 100, LAVAL, QC H7T 0A3, Canada. The company can be reached via phone at +1-450-6864555. MarketBeat Community Rating for Acasti Pharma (CVE ACST)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 85 (Vote Outperform)Underperform Votes: 77 (Vote Underperform)Total Votes: 162MarketBeat's community ratings are surveys of what our community members think about Acasti Pharma and other stocks. Vote "Outperform" if you believe ACST will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ACST will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/16/2019 by MarketBeat.com StaffFeatured Article: How accurate is the Rule of 72?